Scientists test new shot aiming to boost HIV defenses
NCT ID NCT04985760
Summary
This study tested a new experimental HIV vaccine called Trimer 4571 in people already living with HIV who were on stable, effective medication. The main goals were to check if the vaccine was safe and to see if it could help the body's immune system produce powerful antibodies against the virus. The study involved 32 participants who received either the real vaccine or a placebo over several months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AIDS Clinical Trials Unit/The Ohio State University
Columbus, Ohio, 43210, United States
-
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
Conditions
Explore the condition pages connected to this study.